DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Tetrahydrouridine is an investigational drug.
There have been 17 clinical trials for Tetrahydrouridine. The most recent clinical trial was a Phase 2 trial, which was initiated on August 1st 2009.
The most common disease conditions in clinical trials are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, and Head and Neck Neoplasms. The leading clinical trial sponsors are National Cancer Institute (NCI), EpiDestiny, Inc., and City of Hope Medical Center.
Recent Clinical Trials for Tetrahydrouridine
|Effect of Food on the Pharmacokinetics of Decitabine/Tetrahydrouridine Combination Capsules in Healthy Adult Subjects||EpiDestiny, Inc.||Phase 1|
|A Study of Nicotinamide With Oral Tetrahydrouridine and Decitabine to Treat High Risk Sickle Cell Disease||National Institutes of Health (NIH)||Phase 1|
|A Study of Nicotinamide With Oral Tetrahydrouridine and Decitabine to Treat High Risk Sickle Cell Disease||EpiDestiny, Inc.||Phase 1|